StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) shareholders

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Ownership

Who owns Pharma-Bio Serv's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Kirk Wheeler MichelChairman, Director398,6481.74%Jan 14, 2026
Howard SpindelDirector0–Jul 22, 2026
Irving L. WiesenDirector67,2410.29%Jan 14, 2026
Dov PerlyskyDirector2,004,5398.75%Jan 14, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Howard Spindel
Director
Jun 9, 2026Other−42,504––0
Howard Spindel
Director
Jan 5, 2024Option exercise+20,000$1.00$20.00K20,000
Howard Spindel
Director
Jan 5, 2024Gift+1,132––42,504
Howard Spindel
Director
Jan 5, 2024Tax withholding−18,868$1.06$20.00K1,132
Howard Spindel
Director
Jan 5, 2024Gift−1,132––0
Kirk Wheeler Michel
Chairman, Director
Jan 5, 2024Option exercise+20,000$0.76$15.20K57,942
Kirk Wheeler Michel
Chairman, Director
Jan 5, 2024Tax withholding−14,340$1.06$15.20K43,602
Kirk Wheeler Michel
Chairman, Director
Mar 24, 2023Option exercise+20,000$1.00$20.00K55,036
Kirk Wheeler Michel
Chairman, Director
Mar 24, 2023Tax withholding−17,094$1.17$20.00K37,942
Irving L. Wiesen
Director
Mar 24, 2023Option exercise+20,000$0.76$15.20K67,241
Irving L. Wiesen
Director
Mar 24, 2023Tax withholding−12,991$1.17$15.20K54,250
Irving L. Wiesen
Director
Mar 24, 2023Option exercise+20,000$1.00$20.00K64,335
Irving L. Wiesen
Director
Mar 24, 2023Tax withholding−17,094$1.17$20.00K47,241
Dov Perlysky
Director
Mar 24, 2023Option exercise+20,000$0.76$15.20K67,194
Dov Perlysky
Director
Mar 24, 2023Option exercise+20,000$1.00$20.00K64,288
Dov Perlysky
Director
Mar 24, 2023Tax withholding−12,991$1.17$15.20K54,203
Dov Perlysky
Director
Mar 24, 2023Tax withholding−17,094$1.17$20.00K47,194
Pedro J. Lasanta
Chief Financial Officer
Mar 6, 2023Option exercise+8,325$0.99$8.24K126,355
Pedro J. Lasanta
Chief Financial Officer
Mar 6, 2023Tax withholding−7,167$1.15$8.24K119,188
Pedro J. Lasanta
Chief Financial Officer
Mar 6, 2023Option exercise+100,000$0.88$88.00K194,552
Pedro J. Lasanta
Chief Financial Officer
Mar 6, 2023Tax withholding−76,522$1.15$88.00K118,030
Altura Victor Sanchez
President and CEO
Mar 6, 2023Tax withholding−7,167$1.15$8.24K11,382
Altura Victor Sanchez
President and CEO
Mar 6, 2023Option exercise+8,325$0.99$8.24K18,549
Howard Spindel
Director
Jan 9, 2023Option exercise+20,000$0.52$10.40K20,000
Howard Spindel
Director
Jan 9, 2023Gift−6,835––0
Howard Spindel
Director
Jan 9, 2023Tax withholding−13,165$0.79$10.40K6,835
Howard Spindel
Director
Jan 9, 2023Gift+6,835––41,372
Howard Spindel
Director
Jan 4, 2022Gift+2,330––34,537
Howard Spindel
Director
Jan 4, 2022Gift−2,330––0
Howard Spindel
Director
Jan 4, 2022Tax withholding−17,670$1.03$18.20K2,330
Howard Spindel
Director
Jan 4, 2022Option exercise+20,000$0.91$18.20K20,000
Kirk Wheeler Michel
Chairman, Director
Jan 4, 2022Option exercise+20,000$0.91$18.20K52,706
Kirk Wheeler Michel
Chairman, Director
Jan 4, 2022Tax withholding−17,670$1.03$18.20K35,036
Dov Perlysky
Director
Jan 4, 2022Option exercise+20,000$0.91$18.20K57,007
Dov Perlysky
Director
Jan 4, 2022Tax withholding−5,049$1.03$5.20K44,288
Dov Perlysky
Director
Jan 4, 2022Tax withholding−17,670$1.03$18.20K39,337
Dov Perlysky
Director
Jan 4, 2022Option exercise+10,000$0.52$5.20K49,337
Irving L. Wiesen
Director
Jan 4, 2022Tax withholding−17,670$1.03$18.20K34,432
Irving L. Wiesen
Director
Jan 4, 2022Option exercise+20,000$0.52$10.40K54,432
Irving L. Wiesen
Director
Jan 4, 2022Tax withholding−10,097$1.03$10.40K44,335
Irving L. Wiesen
Director
Jan 4, 2022Option exercise+20,000$0.91$18.20K52,102
Elizabeth Plaza
10% owner
Jun 25, 2021Sale−100$1.27$1273,852,921
Elizabeth Plaza
10% owner
Jun 24, 2021Sale−4,000$1.27$5.08K3,853,041
Elizabeth Plaza
10% owner
Jun 23, 2021Sale−12,220$1.32$16.13K3,857,041
Elizabeth Plaza
10% owner
Mar 18, 2021Sale−230,000$1.10$253.00K3,869,241
Dov Perlysky
Director
Jan 4, 2021Tax withholding−13,103$1.45$19.00K42,207
Dov Perlysky
Director
Jan 4, 2021Option exercise+20,000$0.95$19.00K55,310
Irving L. Wiesen
Director
Jan 4, 2021Option exercise+20,000$0.95$19.00K52,276
Irving L. Wiesen
Director
Jan 4, 2021Tax withholding−13,103$1.45$19.00K39,173
Kirk Wheeler Michel
Chairman, Director
Jan 4, 2021Tax withholding−13,103$1.45$19.00K44,660
Kirk Wheeler Michel
Chairman, Director
Jan 4, 2021Option exercise+20,000$0.95$19.00K57,763
Howard Spindel
Director
Jan 3, 2021Gift+6,897––32,207
Howard Spindel
Director
Jan 3, 2021Gift−6,897––0
Howard Spindel
Director
Jan 3, 2021Tax withholding−13,103$1.45$19.00K6,897
Howard Spindel
Director
Jan 3, 2021Option exercise+20,000$0.95$19.00K20,000
Kirk Wheeler Michel
Director
Nov 1, 2019Tax withholding−11,954$0.87$10.40K25,809
Kirk Wheeler Michel
Director
Nov 1, 2019Option exercise+20,000$0.52$10.40K37,763
Pedro J. Lasanta
Chief Financial Officer
Feb 7, 2019Tax withholding−31,401$1.14$35.80K94,552
Pedro J. Lasanta
Chief Financial Officer
Feb 7, 2019Option exercise+41,625$0.86$35.80K125,953
Altura Victor Sanchez
President and CEO
Feb 7, 2019Tax withholding−31,401$1.14$35.80K10,224

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
0.0%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Pharma-Bio Serv's stock actually held short. No settlement fails above the SEC's reporting threshold in the last 90 days.

See a number that looks wrong?